Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.78 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.66 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.66 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.66 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.66 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.66 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.66 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.66 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 3/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7307871 | 0.94 | SMN1; SMN2 (0.74) | SMN1; SMN2HDAC3HDAC1HDAC2HDAC10 | |
| SCHEMBL28668503 | 0.90 | SMN1; SMN2 (0.95) | SMN1; SMN2HDAC3HDAC1HDAC2HDAC10 | |
| SCHEMBL9337868 | 0.90 | SMN1; SMN2 (0.95) | SMN1; SMN2HDAC3HDAC1HDAC2HDAC10 | |
| SCHEMBL38658755 | 0.88 | SMN1; SMN2 (0.91) | SMN1; SMN2HDAC3HDAC1HDAC2HDAC10 | |
| SCHEMBL9639138 | 0.86 | SMN1; SMN2 (0.67) | SMN1; SMN2HDAC3HDAC1HDAC2HDAC10 | |
| SCHEMBL6549000 | 0.85 | SMN1; SMN2 (0.84) | SMN1; SMN2HDAC3HDAC1HDAC2HDAC10 | |
| SCHEMBL8013586 | 0.83 | SMN1; SMN2 (0.81) | SMN1; SMN2HDAC3HDAC1HDAC2HDAC10 | |
| SCHEMBL15480466 | 0.83 | SMN1; SMN2 (0.81) | SMN1; SMN2HDAC3HDAC1HDAC2HDAC10 | |
| SCHEMBL28658599 | 0.82 | SMN1; SMN2 (0.88) | SMN1; SMN2HDAC3HDAC1HDAC2HDAC10 | |
| SCHEMBL10587847 | 0.82 | ALDH1A1 (0.83) | SMN1; SMN2HDAC3HDAC1HDAC2HDAC10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117105879-A | Synthesis method of 5- (4-chlorobutyl) -1-cyclohexyl-1, 2,3, 4-tetrazole | 河北科技大学 | 2023-11-24 | — | — | CN | claimed |
| CN-111233777-A | Synthesis method of N-cyclohexyl-5- (4-chlorobutyl) -1H-tetrazole | 上海立科药物化学有限公司 | 2020-06-05 | — | — | CN | claimed |
| CN-105111190-A | Method for synthesizing cilostazol | ZHEJIANG KINGLYUAN PHARMACEUTICAL COMPANY LTD | 2015-12-02 | — | — | CN | claimed |
| CN-104744436-A | Production method of cilostazol | ZHANG YUN | 2015-07-01 | — | — | CN | claimed |
| CN-100462360-C | N-cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole synthesis method | SHANGHAI RECORD PHARMACEUTICAL (CN) | 2009-02-18 | — | — | CN | claimed |
| CN-1793129-A | Tech. for synthetic (4-chlorobutyl) 1-cyclohexyl-1,2,3,4-tetrazole | XU JIANQIANG (CN) | 2006-06-28 | — | — | CN | claimed |
| CN-1733743-A | N-cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole synthesis method | SHANGHAI RECORD PHARMACEUTICAL (CN) | 2006-02-15 | — | — | CN | claimed |
| CN-117105879-A | Synthesis method of 5- (4-chlorobutyl) -1-cyclohexyl-1, 2,3, 4-tetrazole | 河北科技大学 | 2023-11-24 | — | — | CN | disclosed |
| CN-117105879-A | Synthesis method of 5- (4-chlorobutyl) -1-cyclohexyl-1, 2,3, 4-tetrazole | 河北科技大学 | 2023-11-24 | — | — | CN | disclosed |
| WO-2022106669-A1 | NEW PROCESS FOR THE MANUFACTURE OF TETRAZOLE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2022-05-27 | — | — | WO | disclosed |
| CN-111233777-A | Synthesis method of N-cyclohexyl-5- (4-chlorobutyl) -1H-tetrazole | 上海立科药物化学有限公司 | 2020-06-05 | — | — | CN | disclosed |
| CN-111233777-A | Synthesis method of N-cyclohexyl-5- (4-chlorobutyl) -1H-tetrazole | 上海立科药物化学有限公司 | 2020-06-05 | — | — | CN | disclosed |
| CN-105111190-A | Method for synthesizing cilostazol | ZHEJIANG KINGLYUAN PHARMACEUTICAL COMPANY LTD | 2015-12-02 | — | — | CN | disclosed |
| WO-2006049952-A1 | CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 | ELI LILLY AND COMPANY (US) | 2006-05-11 | — | — | WO | disclosed |
| CN-1733743-A | N-cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole synthesis method | SHANGHAI RECORD PHARMACEUTICAL (CN) | 2006-02-15 | — | — | CN | disclosed |
| CN-1733743-A | N-cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole synthesis method | SHANGHAI RECORD PHARMACEUTICAL (CN) | 2006-02-15 | — | — | CN | disclosed |
| WO-2005019204-A1 | A PROCESS FOR THE PREPARATION OF CILOSTAZOL AND OF THE INTERMEDIATES THEREOF | DIPHARMA S.P.A. (IT) | 2005-03-03 | — | — | WO | disclosed |
| US-4962106-A | Treating platelet activating factor mediated disorders | G. D. SEARLE & CO. (US) | 1990-10-09 | — | — | US | disclosed |
| US-4804658-A | PLATELET-ACTIVATING FACTOR ANTAGONISTS | G. D. SEARLE & CO. (US) | 1989-02-14 | — | — | US | disclosed |
| EP-0260613-A2 | Imidazopyridine derivatives, their preparation and their use as PAF-antagonists | G.D. Searle & Co. (US) | 1988-03-23 | — | — | EP | disclosed |